
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Study Phase : Preclinical
Recipient : Mercury Bio
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Frame Bio Licenses Drug Delivery Technology from Mercury Bio for Regenerative Therapies
Details : Frame Bio can utilize the yEV platform to develop a broad range of regenerative therapeutics that accelerate bone healing and restore collagen.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 17, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Recipient : Mercury Bio
Deal Size : Undisclosed
Deal Type : Licensing Agreement
